Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7453

1.

Predictive Value of MiR-219-1, MiR-938, MiR-34b/c, and MiR-218 Polymorphisms for Gastric Cancer Susceptibility and Prognosis.

Wu Y, Jia Z, Cao D, Wang C, Wu X, You L, Wen S, Pan Y, Cao X, Jiang J.

Dis Markers. 2017;2017:4731891. doi: 10.1155/2017/4731891. Epub 2017 Feb 19.

2.

Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants.

Deben C, Van den Bossche J, Van Der Steen N, Lardon F, Wouters A, de Beeck KO, Hermans C, Jacobs J, Peeters M, Van Camp G, Rolfo C, Deschoolmeester V, Pauwels P.

Tumour Biol. 2017 Feb;39(2):1010428317694327. doi: 10.1177/1010428317694327.

PMID:
28240049
3.

Human RAD 17 Polymorphism at Codon 546 Is Associated with the Risk of Colorectal Cancer.

Yasuda Y, Sakai A, Ito S, Sasai K, Yamamoto H, Matsubara N, Ouchida M, Katayama H, Shimizu K.

Acta Med Okayama. 2017 Feb;71(1):59-68. doi: 10.18926/AMO/54826.

4.

X-ray cross-complementing groups 1 rs1799782 C>T polymorphisms and colorectal cancer susceptibility: A meta-analysis based on Chinese Han population.

Wang L, Qian J, Ying C, Zhuang Y, Shang X, Xu F.

J Cancer Res Ther. 2016 Dec;12(Supplement):C264-C267. doi: 10.4103/0973-1482.200753.

5.
6.
7.

Association between GPX1 Pro189Leu polymorphism and the occurrence of bladder cancer in Morocco.

Hadami K, Ameziane El Hassani R, Ameur A, Dakka N, Abbar M, Al Bouzidi A, Attaleb M, El Mzibri M.

Cell Mol Biol (Noisy-le-grand). 2016 Dec 30;62(14):38-43. doi: 10.14715/cmb/ 2016.62.14.6.

PMID:
28145855
8.

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?

Qvick A, Sorbe B, Helenius G, Karlsson MG, Lillsunde Larsson G.

Med Oncol. 2017 Mar;34(3):36. doi: 10.1007/s12032-017-0893-6. Epub 2017 Jan 31.

9.

Protective role of +294 T/C (rs2016520) polymorphism of PPARD in Mexican patients with colorectal cancer.

Rosales-Reynoso MA, Wence-Chavez LI, Arredondo-Valdez AR, Dumois-Petersen S, Barros-Núñez P, Gallegos-Arreola MP, Flores-Martínez SE, Sánchez-Corona J.

Genet Mol Res. 2017 Jan 23;16(1). doi: 10.4238/gmr16019324.

PMID:
28128413
10.

Meta-analysis of TP73 polymorphism and cervical cancer.

Feng H, Sui L, Du M, Wang Q.

Genet Mol Res. 2017 Jan 23;16(1). doi: 10.4238/gmr16016571.

PMID:
28128397
11.

Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.

Rezende LM, Marson FA, Lima CS, Bertuzzo CS.

Gene. 2017 Apr 15;608:73-78. doi: 10.1016/j.gene.2017.01.010. Epub 2017 Jan 18.

PMID:
28109853
12.

Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk.

Wu JB, Zhai JF, Yang J.

Genet Mol Res. 2016 Dec 23;15(4). doi: 10.4238/gmr15048570.

PMID:
28081274
13.

Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.

Cao Y, Zhang G, Wang P, Zhou J, Gan W, Song Y, Huang L, Zhang Y, Luo G, Gong J, Zhang L.

BMC Gastroenterol. 2017 Jan 5;17(1):2. doi: 10.1186/s12876-016-0561-x.

14.

Polymorphisms of glucose-regulated protein 78 and clinical relevance of neuroblastoma: Risk and prognosis.

Zhang J, Wang J, Liu Q, Gao J, Wang Q.

J Cancer Res Ther. 2016 Jul-Sep;12(3):1178-1183. doi: 10.4103/0973-1482.193119.

15.

Strong cis-acting expression quantitative trait loci for the genes encoding SNHG5 and PEX6.

Lee J, Ryu J, Lee C.

Medicine (Baltimore). 2016 Dec;95(52):e5793. doi: 10.1097/MD.0000000000005793.

16.

Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.

Shimoda Y, Nagashima T, Urakami K, Tanabe T, Saito J, Naruoka A, Serizawa M, Mochizuki T, Ohshima K, Ohnami S, Ohnami S, Kusuhara M, Yamaguchi K.

Biomed Res. 2016;37(6):367-379. doi: 10.2220/biomedres.37.367.

17.

Single-Nucleotide Polymorphisms and Cancer Risk, Tumor Recurrence, or Survival of Head and Neck Cancer Patients.

Laytragoon-Lewin N, Cederblad L, Andersson BÅ, Olin M, Nilsson M, Rutqvist LE, Lundgren J, Engström M, Tytor W, Löfgren S, Lewin F.

Oncology. 2017;92(3):161-169. doi: 10.1159/000452278. Epub 2016 Dec 21.

PMID:
27997918
18.

Role of GSK3β in breast cancer susceptibility.

Aristizabal-Pachon AF, Castillo WO.

Cancer Biomark. 2017;18(2):169-175. doi: 10.3233/CBM-160120.

PMID:
27983530
19.

Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome.

Knebel B, Lehr S, Janssen OE, Hahn S, Jacob S, Nitzgen U, Müller-Wieland D, Kotzka J.

Mol Biol Rep. 2017 Feb;44(1):51-61. doi: 10.1007/s11033-016-4080-1. Epub 2016 Nov 22.

PMID:
27878529
20.

Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development.

Wang B, Yang H, Shen L, Wang J, Pu W, Chen Z, Shen X, Fu J, Zhuang Z.

Cell Physiol Biochem. 2016;40(1-2):391-399. Epub 2016 Nov 21.

Supplemental Content

Loading ...
Support Center